Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 07 April, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo
Stock Ticker - BSE: 543275 | NSE: ANURAS

Anupam Rasayan India Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: April 5, 2025, 9:34 am

Market Cap 8,394 Cr.
Current Price 764
High / Low 910/601
Stock P/E105
Book Value 253
Dividend Yield0.16 %
ROCE8.89 %
ROE4.91 %
Face Value 10.0
PEG Ratio170.09

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Anupam Rasayan India Ltd

Competitors of Anupam Rasayan India Ltd

Stock Name Market Cap Current Price High / Low Stock P/E Book Value Dividend Yield ROCE ROE Face Value
HP Adhesives Ltd 483 Cr. 52.6 109/42.625.0 19.20.57 %17.7 %12.6 % 2.00
Haryana Leather Chemicals Ltd 37.3 Cr. 75.9 124/62.69.05 87.21.32 %8.96 %7.25 % 10.0
Hardcastle & Waud Mfg Co Ltd 48.3 Cr. 710 1,355/60027.6 6630.00 %7.00 %5.98 % 10.0
Grauer & Weil (India) Ltd 3,909 Cr. 86.2 120/72.224.3 19.20.58 %26.1 %19.6 % 1.00
DMCC Speciality Chemicals Ltd 715 Cr. 287 453/24934.3 85.40.35 %7.55 %2.89 % 10.0
Industry Average12,122.04 Cr690.5646.64173.820.39%13.99%10.73%6.44

All Competitor Stocks of Anupam Rasayan India Ltd

Quarterly Result

MetricDec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Sales 266325344393392480386392296401254294390
Expenses 191220245282281363285285216308201214266
Operating Profit 751059911111111710110779935380124
OPM % 28%32%29%28%28%24%26%27%27%23%21%27%32%
Other Income 5-7-8-10-32412321262-4
Interest 5141216142018202526222732
Depreciation 16151618181919202021212229
Profit before tax 596862677510377713658163459
Tax % 36%33%32%29%28%29%32%31%28%30%25%10%9%
Net Profit 38464248547352492640123154
EPS in Rs 3.794.603.964.154.005.283.593.781.682.820.361.522.56

Last Updated: February 28, 2025, 3:32 pm

Below is a detailed analysis of the quarterly data for Anupam Rasayan India Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

  • For Sales, as of Dec 2024, the value is 390.00 Cr.. The value appears strong and on an upward trend. It has increased from 294.00 Cr. (Sep 2024) to 390.00 Cr., marking an increase of 96.00 Cr..
  • For Expenses, as of Dec 2024, the value is 266.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 214.00 Cr. (Sep 2024) to 266.00 Cr., marking an increase of 52.00 Cr..
  • For Operating Profit, as of Dec 2024, the value is 124.00 Cr.. The value appears strong and on an upward trend. It has increased from 80.00 Cr. (Sep 2024) to 124.00 Cr., marking an increase of 44.00 Cr..
  • For OPM %, as of Dec 2024, the value is 32.00%. The value appears strong and on an upward trend. It has increased from 27.00% (Sep 2024) to 32.00%, marking an increase of 5.00%.
  • For Other Income, as of Dec 2024, the value is -4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Sep 2024) to -4.00 Cr., marking a decrease of 6.00 Cr..
  • For Interest, as of Dec 2024, the value is 32.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 27.00 Cr. (Sep 2024) to 32.00 Cr., marking an increase of 5.00 Cr..
  • For Depreciation, as of Dec 2024, the value is 29.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 22.00 Cr. (Sep 2024) to 29.00 Cr., marking an increase of 7.00 Cr..
  • For Profit before tax, as of Dec 2024, the value is 59.00 Cr.. The value appears strong and on an upward trend. It has increased from 34.00 Cr. (Sep 2024) to 59.00 Cr., marking an increase of 25.00 Cr..
  • For Tax %, as of Dec 2024, the value is 9.00%. The value appears to be improving (decreasing) as expected. It has decreased from 10.00% (Sep 2024) to 9.00%, marking a decrease of 1.00%.
  • For Net Profit, as of Dec 2024, the value is 54.00 Cr.. The value appears strong and on an upward trend. It has increased from 31.00 Cr. (Sep 2024) to 54.00 Cr., marking an increase of 23.00 Cr..
  • For EPS in Rs, as of Dec 2024, the value is 2.56. The value appears strong and on an upward trend. It has increased from 1.52 (Sep 2024) to 2.56, marking an increase of 1.04.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 7, 2025, 5:20 pm

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Sales 5025298111,0741,6021,4751,339
Expenses 4083946177691,1711,094989
Operating Profit 93135194305431381351
OPM % 19%25%24%28%27%26%26%
Other Income 1911268103016
Interest 244569316389107
Depreciation 23295260718092
Profit before tax 6672100222308242168
Tax % 24%26%30%31%30%31%
Net Profit 495370152217167138
EPS in Rs 9.8510.647.0415.1816.8411.727.26
Dividend Payout % -0%-0%7%7%15%11%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)8.16%32.08%117.14%42.76%-23.04%
Change in YoY Net Profit Growth (%)0.00%23.91%85.07%-74.38%-65.80%

Anupam Rasayan India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 5 years from 2019-2020 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:%
5 Years:24%
3 Years:22%
TTM:-14%
Compounded Profit Growth
10 Years:%
5 Years:21%
3 Years:21%
TTM:-48%
Stock Price CAGR
10 Years:%
5 Years:%
3 Years:-3%
1 Year:-15%
Return on Equity
10 Years:%
5 Years:7%
3 Years:7%
Last Year:5%

Last Updated: Unknown

Balance Sheet

Last Updated: December 14, 2024, 2:16 pm

MonthMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital 5050100100107110110
Reserves 4325151,4731,6272,2652,6512,673
Borrowings 6948474238368221,0701,327
Other Liabilities 146252301327584771808
Total Liabilities 1,3231,6642,2982,8913,7784,6024,918
Fixed Assets 6819771,1151,2021,4171,5012,020
CWIP 1911014344120609267
Investments 000149676719
Other Assets 4515861,1401,4962,1732,4242,613
Total Assets 1,3231,6642,2982,8913,7784,6024,918

Below is a detailed analysis of the balance sheet data for Anupam Rasayan India Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2024, the value is ₹110.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 110.00 Cr..
  • For Reserves, as of Sep 2024, the value is ₹2,673.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,651.00 Cr. (Mar 2024) to ₹2,673.00 Cr., marking an increase of 22.00 Cr..
  • For Borrowings, as of Sep 2024, the value is ₹1,327.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1,070.00 Cr. (Mar 2024) to ₹1,327.00 Cr., marking an increase of 257.00 Cr..
  • For Other Liabilities, as of Sep 2024, the value is ₹808.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 771.00 Cr. (Mar 2024) to ₹808.00 Cr., marking an increase of 37.00 Cr..
  • For Total Liabilities, as of Sep 2024, the value is ₹4,918.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,602.00 Cr. (Mar 2024) to ₹4,918.00 Cr., marking an increase of 316.00 Cr..
  • For Fixed Assets, as of Sep 2024, the value is ₹2,020.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,501.00 Cr. (Mar 2024) to ₹2,020.00 Cr., marking an increase of 519.00 Cr..
  • For CWIP, as of Sep 2024, the value is ₹267.00 Cr.. The value appears to be declining and may need further review. It has decreased from 609.00 Cr. (Mar 2024) to ₹267.00 Cr., marking a decrease of 342.00 Cr..
  • For Investments, as of Sep 2024, the value is ₹19.00 Cr.. The value appears to be declining and may need further review. It has decreased from 67.00 Cr. (Mar 2024) to ₹19.00 Cr., marking a decrease of 48.00 Cr..
  • For Other Assets, as of Sep 2024, the value is ₹2,613.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,424.00 Cr. (Mar 2024) to ₹2,613.00 Cr., marking an increase of 189.00 Cr..
  • For Total Assets, as of Sep 2024, the value is ₹4,918.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,602.00 Cr. (Mar 2024) to ₹4,918.00 Cr., marking an increase of 316.00 Cr..

Notably, the Reserves (2,673.00 Cr.) exceed the Borrowings (1,327.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +39951-17129259
Cash from Investing Activity +-250-178-193-412-523-392
Cash from Financing Activity +206102416384371395
Net Cash Flow-619224-19914062

Free Cash Flow

MonthMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow-601.00-712.00-229.00-531.00-391.00380.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days8889929595143
Inventory Days277515530852483627
Days Payable105226215225167247
Cash Conversion Cycle260379408722410524
Working Capital Days168185233328253344
ROCE %9%10%11%13%9%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Promoters65.18%65.17%65.16%60.96%60.80%60.77%60.73%61.41%61.26%61.23%61.23%61.19%
FIIs5.73%4.98%4.59%8.19%8.52%9.79%10.26%9.13%8.07%7.14%7.00%7.46%
DIIs3.68%4.40%4.40%6.18%4.98%3.74%1.76%2.51%2.56%2.56%2.30%2.32%
Public25.41%25.45%25.84%24.67%25.68%25.71%27.25%26.96%28.10%29.06%29.47%29.06%
No. of Shareholders65,07165,87071,49273,32666,50761,50461,12960,08957,62362,21863,86660,938

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Quant Small Cap Fund2,086,5161.26198.0711,0152025-04-0518842.5%
Aditya Birla Sun Life Pure Value Fund321,8440.5430.5511,0152025-04-052821.87%
Nippon India Nifty Smallcap 250 Index Fund16,0670.141.5311,0152025-04-0545.86%
Axis Nifty Smallcap 50 Index Fund11,0150.431.0511,0152025-04-050%
Motilal Oswal Nifty Smallcap 250 Index Fund9,8230.140.9311,0152025-04-05-10.82%
Aditya Birla Sun Life Nifty Smallcap 50 Index Fund8,7540.440.8311,0152025-04-05-20.53%
SBI Nifty Smallcap 250 Index Fund8,1580.140.7711,0152025-04-05-25.94%
ICICI Prudential Nifty Smallcap 250 Index Fund3,7250.140.3511,0152025-04-05-66.18%
Motilal Oswal Nifty 500 Index Fund9720.010.0911,0152025-04-05-91.18%
Edelweiss Nifty Smallcap 250 Index Fund4420.140.0411,0152025-04-05-95.99%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 15.4820.9115.228.5610.64
Diluted EPS (Rs.) 15.4620.8615.188.566.97
Cash EPS (Rs.) 22.5126.6621.1112.2016.38
Book Value[Excl.RevalReserv]/Share (Rs.) 251.49233.38172.26157.46113.08
Book Value[Incl.RevalReserv]/Share (Rs.) 251.49233.38172.26157.46113.08
Revenue From Operations / Share (Rs.) 134.36149.06106.3481.15105.78
PBDIT / Share (Rs.) 37.4340.9431.1422.0429.13
PBIT / Share (Rs.) 30.1734.3225.1416.8723.39
PBT / Share (Rs.) 22.0228.4922.0710.0114.33
Net Profit / Share (Rs.) 15.2520.0415.127.0410.64
NP After MI And SOA / Share (Rs.) 11.7116.8315.187.0410.64
PBDIT Margin (%) 27.8527.4629.2827.1527.53
PBIT Margin (%) 22.4523.0223.6420.7822.10
PBT Margin (%) 16.3919.1120.7512.3313.55
Net Profit Margin (%) 11.3513.4414.218.6610.06
NP After MI And SOA Margin (%) 8.7111.2814.278.6610.06
Return on Networth / Equity (%) 4.657.628.814.469.41
Return on Capital Employeed (%) 10.0712.4310.978.979.99
Return On Assets (%) 2.794.785.263.053.19
Long Term Debt / Equity (X) 0.070.140.280.150.92
Total Debt / Equity (X) 0.360.330.460.241.35
Asset Turnover Ratio (%) 0.350.480.410.400.35
Current Ratio (X) 1.692.602.432.591.12
Quick Ratio (X) 0.891.460.981.420.51
Inventory Turnover Ratio (X) 0.690.851.021.191.20
Dividend Payout Ratio (NP) (%) 16.715.783.280.000.00
Dividend Payout Ratio (CP) (%) 10.324.152.350.000.00
Earning Retention Ratio (%) 83.2994.2296.720.000.00
Cash Earning Retention Ratio (%) 89.6895.8597.650.000.00
Interest Coverage Ratio (X) 4.597.0210.133.213.22
Interest Coverage Ratio (Post Tax) (X) 2.874.445.922.032.18
Enterprise Value (Cr.) 10438.779646.448830.954991.830.00
EV / Net Operating Revenue (X) 7.086.028.286.160.00
EV / EBITDA (X) 25.4021.9328.2922.670.00
MarketCap / Net Operating Revenue (X) 6.475.807.736.040.00
Retention Ratios (%) 83.2894.2196.710.000.00
Price / BV (X) 3.453.914.773.110.00
Price / Net Operating Revenue (X) 6.475.807.736.040.00
EarningsYield 0.010.010.010.010.00

After reviewing the key financial ratios for Anupam Rasayan India Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
  • For Basic EPS (Rs.), as of Mar 24, the value is 15.48. This value is within the healthy range. It has decreased from 20.91 (Mar 23) to 15.48, marking a decrease of 5.43.
  • For Diluted EPS (Rs.), as of Mar 24, the value is 15.46. This value is within the healthy range. It has decreased from 20.86 (Mar 23) to 15.46, marking a decrease of 5.40.
  • For Cash EPS (Rs.), as of Mar 24, the value is 22.51. This value is within the healthy range. It has decreased from 26.66 (Mar 23) to 22.51, marking a decrease of 4.15.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 251.49. It has increased from 233.38 (Mar 23) to 251.49, marking an increase of 18.11.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 251.49. It has increased from 233.38 (Mar 23) to 251.49, marking an increase of 18.11.
  • For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 134.36. It has decreased from 149.06 (Mar 23) to 134.36, marking a decrease of 14.70.
  • For PBDIT / Share (Rs.), as of Mar 24, the value is 37.43. This value is within the healthy range. It has decreased from 40.94 (Mar 23) to 37.43, marking a decrease of 3.51.
  • For PBIT / Share (Rs.), as of Mar 24, the value is 30.17. This value is within the healthy range. It has decreased from 34.32 (Mar 23) to 30.17, marking a decrease of 4.15.
  • For PBT / Share (Rs.), as of Mar 24, the value is 22.02. This value is within the healthy range. It has decreased from 28.49 (Mar 23) to 22.02, marking a decrease of 6.47.
  • For Net Profit / Share (Rs.), as of Mar 24, the value is 15.25. This value is within the healthy range. It has decreased from 20.04 (Mar 23) to 15.25, marking a decrease of 4.79.
  • For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 11.71. This value is within the healthy range. It has decreased from 16.83 (Mar 23) to 11.71, marking a decrease of 5.12.
  • For PBDIT Margin (%), as of Mar 24, the value is 27.85. This value is within the healthy range. It has increased from 27.46 (Mar 23) to 27.85, marking an increase of 0.39.
  • For PBIT Margin (%), as of Mar 24, the value is 22.45. This value exceeds the healthy maximum of 20. It has decreased from 23.02 (Mar 23) to 22.45, marking a decrease of 0.57.
  • For PBT Margin (%), as of Mar 24, the value is 16.39. This value is within the healthy range. It has decreased from 19.11 (Mar 23) to 16.39, marking a decrease of 2.72.
  • For Net Profit Margin (%), as of Mar 24, the value is 11.35. This value exceeds the healthy maximum of 10. It has decreased from 13.44 (Mar 23) to 11.35, marking a decrease of 2.09.
  • For NP After MI And SOA Margin (%), as of Mar 24, the value is 8.71. This value is within the healthy range. It has decreased from 11.28 (Mar 23) to 8.71, marking a decrease of 2.57.
  • For Return on Networth / Equity (%), as of Mar 24, the value is 4.65. This value is below the healthy minimum of 15. It has decreased from 7.62 (Mar 23) to 4.65, marking a decrease of 2.97.
  • For Return on Capital Employeed (%), as of Mar 24, the value is 10.07. This value is within the healthy range. It has decreased from 12.43 (Mar 23) to 10.07, marking a decrease of 2.36.
  • For Return On Assets (%), as of Mar 24, the value is 2.79. This value is below the healthy minimum of 5. It has decreased from 4.78 (Mar 23) to 2.79, marking a decrease of 1.99.
  • For Long Term Debt / Equity (X), as of Mar 24, the value is 0.07. This value is below the healthy minimum of 0.2. It has decreased from 0.14 (Mar 23) to 0.07, marking a decrease of 0.07.
  • For Total Debt / Equity (X), as of Mar 24, the value is 0.36. This value is within the healthy range. It has increased from 0.33 (Mar 23) to 0.36, marking an increase of 0.03.
  • For Asset Turnover Ratio (%), as of Mar 24, the value is 0.35. It has decreased from 0.48 (Mar 23) to 0.35, marking a decrease of 0.13.
  • For Current Ratio (X), as of Mar 24, the value is 1.69. This value is within the healthy range. It has decreased from 2.60 (Mar 23) to 1.69, marking a decrease of 0.91.
  • For Quick Ratio (X), as of Mar 24, the value is 0.89. This value is below the healthy minimum of 1. It has decreased from 1.46 (Mar 23) to 0.89, marking a decrease of 0.57.
  • For Inventory Turnover Ratio (X), as of Mar 24, the value is 0.69. This value is below the healthy minimum of 4. It has decreased from 0.85 (Mar 23) to 0.69, marking a decrease of 0.16.
  • For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 16.71. This value is below the healthy minimum of 20. It has increased from 5.78 (Mar 23) to 16.71, marking an increase of 10.93.
  • For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 10.32. This value is below the healthy minimum of 20. It has increased from 4.15 (Mar 23) to 10.32, marking an increase of 6.17.
  • For Earning Retention Ratio (%), as of Mar 24, the value is 83.29. This value exceeds the healthy maximum of 70. It has decreased from 94.22 (Mar 23) to 83.29, marking a decrease of 10.93.
  • For Cash Earning Retention Ratio (%), as of Mar 24, the value is 89.68. This value exceeds the healthy maximum of 70. It has decreased from 95.85 (Mar 23) to 89.68, marking a decrease of 6.17.
  • For Interest Coverage Ratio (X), as of Mar 24, the value is 4.59. This value is within the healthy range. It has decreased from 7.02 (Mar 23) to 4.59, marking a decrease of 2.43.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 2.87. This value is below the healthy minimum of 3. It has decreased from 4.44 (Mar 23) to 2.87, marking a decrease of 1.57.
  • For Enterprise Value (Cr.), as of Mar 24, the value is 10,438.77. It has increased from 9,646.44 (Mar 23) to 10,438.77, marking an increase of 792.33.
  • For EV / Net Operating Revenue (X), as of Mar 24, the value is 7.08. This value exceeds the healthy maximum of 3. It has increased from 6.02 (Mar 23) to 7.08, marking an increase of 1.06.
  • For EV / EBITDA (X), as of Mar 24, the value is 25.40. This value exceeds the healthy maximum of 15. It has increased from 21.93 (Mar 23) to 25.40, marking an increase of 3.47.
  • For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 6.47. This value exceeds the healthy maximum of 3. It has increased from 5.80 (Mar 23) to 6.47, marking an increase of 0.67.
  • For Retention Ratios (%), as of Mar 24, the value is 83.28. This value exceeds the healthy maximum of 70. It has decreased from 94.21 (Mar 23) to 83.28, marking a decrease of 10.93.
  • For Price / BV (X), as of Mar 24, the value is 3.45. This value exceeds the healthy maximum of 3. It has decreased from 3.91 (Mar 23) to 3.45, marking a decrease of 0.46.
  • For Price / Net Operating Revenue (X), as of Mar 24, the value is 6.47. This value exceeds the healthy maximum of 3. It has increased from 5.80 (Mar 23) to 6.47, marking an increase of 0.67.
  • For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Anupam Rasayan India Ltd as of April 7, 2025 is: 1,045.14

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of April 7, 2025, Anupam Rasayan India Ltd is Undervalued by 36.80% compared to the current share price 764.00

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The company has higher reserves (1,662.29 cr) compared to borrowings (859.86 cr), indicating strong financial stability.
  2. The company has shown consistent growth in sales (263.71 cr) and profit (168.29 cr) over the years.
  1. The stock has a low average ROCE of 8.67%, which may not be favorable.
  2. The stock has a high average Working Capital Days of 251.83, which may not be favorable.
  3. The stock has a high average Cash Conversion Cycle of 450.50, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Anupam Rasayan India Ltd:
    1. Net Profit Margin: 11.35%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 10.07% (Industry Average ROCE: 13.99%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 4.65% (Industry Average ROE: 10.73%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 2.87
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 0.89
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 105 (Industry average Stock P/E: 46.64)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.36
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Anupam Rasayan India Ltd. is a Public Limited Listed company incorporated on 30/09/2003 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24231GJ2003PLC042988 and registration number is 042988. Currently Company is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company's Total Operating Revenue is Rs. 1128.70 Cr. and Equity Capital is Rs. 109.79 Cr. for the Year ended 31/03/2024.
INDUSTRYADDRESSCONTACT
Chemicals - Speciality - Others1101 to 1107, 11th Floor, Icon Rio, Behind Icon Business Centre, Surat Gujarat 395007investors@anupamrasayan.com
http://www.anupamrasayan.com
Management
NamePosition Held
Dr. Kiran C PatelChairman & Non-Exe.Director
Mrs. Mona A DesaiVice Chairman & Whole Time Dir
Mr. Anand S DesaiManaging Director
Dr. Anuj Hemantbhai ThakarWhole Time Director
Dr. Namrata Dharmendra JariwalaIndependent Director
Mr. Vijay Kumar BatraIndependent Director
Mr. Vinesh Prabhakar SadekarIndependent Director
Mr. Hetul Krishnakant MehtaIndependent Director

FAQ

What is the intrinsic value of Anupam Rasayan India Ltd?

Anupam Rasayan India Ltd's intrinsic value (as of 07 April 2025) is ₹1045.14 — 36.80% higher the current market price of 764.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 8,394 Cr. market cap, FY2025-2026 high/low of ₹910/601, reserves of 2,673 Cr, and liabilities of 4,918 Cr.

What is the Market Cap of Anupam Rasayan India Ltd?

The Market Cap of Anupam Rasayan India Ltd is 8,394 Cr..

What is the current Stock Price of Anupam Rasayan India Ltd as on 07 April 2025?

The current stock price of Anupam Rasayan India Ltd as on 07 April 2025 is 764.

What is the High / Low of Anupam Rasayan India Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Anupam Rasayan India Ltd stocks is ₹910/601.

What is the Stock P/E of Anupam Rasayan India Ltd?

The Stock P/E of Anupam Rasayan India Ltd is 105.

What is the Book Value of Anupam Rasayan India Ltd?

The Book Value of Anupam Rasayan India Ltd is 253.

What is the Dividend Yield of Anupam Rasayan India Ltd?

The Dividend Yield of Anupam Rasayan India Ltd is 0.16 %.

What is the ROCE of Anupam Rasayan India Ltd?

The ROCE of Anupam Rasayan India Ltd is 8.89 %.

What is the ROE of Anupam Rasayan India Ltd?

The ROE of Anupam Rasayan India Ltd is 4.91 %.

What is the Face Value of Anupam Rasayan India Ltd?

The Face Value of Anupam Rasayan India Ltd is 10.0.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Anupam Rasayan India Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE